Filing Details
- Accession Number:
- 0001493152-16-010274
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-24 17:57:38
- Reporting Period:
- 2016-05-24
- Filing Date:
- 2016-05-24
- Accepted Time:
- 2016-05-24 17:57:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1321834 | Akers Biosciences Inc | AKER | In Vitro & In Vivo Diagnostic Substances (2835) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1661118 | J John Gormally | 80 Walsh Drive Mahwah NJ 07430 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-05-24 | 69 | $2.19 | 69 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-05-24 | 1,000 | $2.20 | 1,069 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-05-24 | 100 | $2.23 | 1,169 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-05-24 | 1,131 | $2.25 | 2,300 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-05-24 | 200 | $2.24 | 2,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |